GHRP-2 vs. GHRP-6 vs. Hexarelin: Comparing the Three Major GHRPs
Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.
Overview
GHRP-2, GHRP-6, and Hexarelin are the three most studied synthetic growth hormone-releasing peptides (GHRPs). All three act as ghrelin receptor (GHSR-1a) agonists, but they differ significantly in binding affinity, GH-releasing potency, ghrelin-like side effects, and secondary receptor interactions. Understanding these differences is essential for selecting the appropriate GHRP for specific research applications.
Structural Comparison
| Parameter | GHRP-2 | GHRP-6 | Hexarelin | |-----------|--------|--------|-----------| | Amino acids | 6 | 6 | 6 | | Sequence | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2 | | Key modification | 2-naphthylalanine | Tryptophan-based | 2-methyltryptophan | | GHSR-1a affinity | High | Moderate | Highest |
The key structural difference is the substitution at position 2: GHRP-2 uses D-2-naphthylalanine, GHRP-6 uses D-tryptophan, and Hexarelin uses D-2-methyltryptophan. The methylation in Hexarelin increases GHSR-1a binding affinity, explaining its superior GH-releasing potency.
GH-Releasing Potency
At equimolar doses, the relative GH-releasing potency is:
Hexarelin > GHRP-2 > GHRP-6
Quantitatively, studies have shown: - Hexarelin produces approximately 2-3x the peak GH response of GHRP-6 - GHRP-2 produces approximately 1.5-2x the peak GH response of GHRP-6 - All three show synergistic GH release when combined with GHRH or GHRH analogues
Ghrelin-Like Effects
Ghrelin, the endogenous GHSR-1a ligand, has multiple effects beyond GH release including appetite stimulation, gastric motility, and metabolic regulation. The three GHRPs differ in how strongly they replicate these ghrelin-like effects:
| Effect | GHRP-2 | GHRP-6 | Hexarelin | |--------|--------|--------|-----------| | Appetite stimulation | Moderate | Strong | Moderate | | Gastric motility | Moderate | Strong | Moderate | | Cortisol elevation | Moderate | Mild | Significant | | Prolactin elevation | Moderate | Mild | Significant |
GHRP-6 produces the strongest appetite-stimulating and gastric motility effects among the three, consistent with its closer structural resemblance to the ghrelin pharmacophore.
Hexarelin produces the most significant cortisol and prolactin elevation, which is an important consideration in research design — studies measuring cortisol or prolactin as outcomes may be confounded by Hexarelin's effects on these hormones.
Unique Properties
GHRP-2: The most "balanced" GHRP — high GH potency with moderate ghrelin-like effects and moderate cortisol/prolactin elevation. The most commonly used GHRP in clinical research studies.
GHRP-6: The most "ghrelin-like" GHRP — strongest appetite and gastric effects, lowest cortisol/prolactin elevation. Best suited for research specifically studying the ghrelin pathway or gastric function.
Hexarelin: The most potent GH secretagogue and the only GHRP with demonstrated cardioprotective effects through CD36 receptor binding. Best suited for research requiring maximum GH stimulation or cardiac protection studies.
Receptor Desensitization Comparison
| Peptide | Desensitization Rate | Recovery Time | |---------|---------------------|---------------| | Hexarelin | Rapid (~50% reduction in 4 weeks) | ~4 weeks washout | | GHRP-2 | Moderate | ~2 weeks washout | | GHRP-6 | Moderate | ~2 weeks washout | | Ipamorelin | Minimal | Minimal |
Hexarelin's rapid receptor desensitization is a critical practical consideration in research design. Studies using Hexarelin for more than 4 weeks should incorporate cycling protocols.
Research Protocol Selection Guide
| Research Goal | Recommended GHRP | |--------------|-----------------| | Maximum GH stimulation | Hexarelin | | Cardiac protection research | Hexarelin (CD36 mechanism) | | Ghrelin pathway research | GHRP-6 | | Appetite/gastric research | GHRP-6 | | Balanced GH research | GHRP-2 | | Minimal cortisol confounding | GHRP-6 or Ipamorelin | | Long-duration studies (>4 weeks) | GHRP-2 or GHRP-6 (less desensitization) |
Summary
GHRP-2, GHRP-6, and Hexarelin are complementary research tools within the GHRP class. Hexarelin provides maximum GH potency and unique cardioprotective properties; GHRP-6 provides the most authentic ghrelin-like pharmacology; GHRP-2 provides a balanced profile suitable for most GH research applications. Protocol selection should be guided by the specific research question and the need to control for cortisol, prolactin, and appetite confounders.
See Also: Hexarelin Deep Dive: The Most Potent GHRP | Sermorelin vs. Ipamorelin vs. CJC-1295 Comparison
Was this article helpful?
Click a star to rate
All compounds referenced in this article are available as research-grade peptides, independently verified by Freedom Diagnostics.